Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 3Phase 1 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2Phase 4 1Phase 3 1

Status

Completed 7Terminated 6Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 143Colorectal Neoplasms 97Carcinoma, Non-Small-Cell Lung 97Carcinoma, Hepatocellular 69Stomach Neoplasms 65Rectal Neoplasms 54Neoplasms 53Lung Neoplasms 45Colonic Neoplasms 41Nasopharyngeal Carcinoma 39Leukemia, Myeloid, Acute 39Prostatic Neoplasms 38Lymphoma, Large B-Cell, Diffuse 38Uterine Cervical Neoplasms 36Neoplasm Metastasis 33Ovarian Neoplasms 32Esophageal Neoplasms 32Multiple Myeloma 31Lymphoma 31Lymphoma, Follicular 30Leukemia 28Pancreatic Neoplasms 27Recurrence 22Head and Neck Neoplasms 22Brain Neoplasms 21Urinary Bladder Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Non-Hodgkin 19Squamous Cell Carcinoma of Head and Neck 17Lymphoma, Mantle-Cell 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Bone Neoplasms × Clear all
NCT04842071 2024-02-07

18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Phase 3 Unknown
2,500 enrolled
Sarcoma

Bone Diseases, Bone Neoplasms, Communicable Diseases, Joint Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡